Erick Lucera, EVP, CFO: Editas Medicine EDIT Sell · Filed 24/05/22

Trade details

Type: Insider sale
Amount: $125,310.57
Shares · price: 22,337 sh · $5.61 a share
Held after: 116,829 sh
Stock: Editas Medicine EDIT
Person: Erick LuceraEVP, CFO
Trade date: 24/05/20
Filed: 24/05/22
Days to filing: 2 days

Sold 16.1% of holdings

Share of holding sold: 16.1%

Editas Medicine trades, last 26 weeks

What else happened in Editas Medicine around then

Filed or reported within 30 days of the trade day · 24/04/20~24/06/19

Erick Lucera's recent trades

Erick LuceraCFO
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$47.2K
1,797 sh
$47.2K
Filed 08/13
Traded 08/13
Erick LuceraCFO
SellDyne Therapeutics
Sell
Dyne Therapeutics
DYN
$48.1K
2,362 sh
$48.1K
Filed 06/26
Traded 06/25
Erick LuceraCFO
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$48.1K
2,362 sh
$48.1K
Filed 06/25
Traded 06/25
Erick LuceraCFO
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$26.6K
1,448 sh
$26.6K
Filed 05/14
Traded 05/13
Erick LuceraCFO
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$26.6K
1,448 sh
$26.6K
Filed 05/13
Traded 05/13